Fundraising FoxAlexar Therapeutics
Malvern, US · Founded 2013 · Delaware corporation · 2 known investors
Find your way into Alexar Therapeutics
Sign up to see every warm intro you have to Alexar Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Alexar Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Alexar Therapeutics was founded in 2013 by Raju Mohan.
RM
KA
Kamil Ali-JacksonExecutive
DP
David PfeifferExecutive
Board
Investors · 2
New Science VenturesreportedGreenwich · $2M – $8M
How we know: funding news · Not right? Tell us
Third Point VenturesreportedMenlo Park
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$19M disclosed across 3 rounds · 2014–2018
▶$4.3MraisedApr 2020 · 11 investors · PharmaceuticalsRule 506(b)
▶$4.3MraisedApr 2020 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Stephen TullmanExecutive Officer, Director
- Jason HongDirector
- David PfeifferExecutive Officer, Director
- Somasundaram SubramaniamDirector
- Neal WalkerDirector
- Offering amount
- $6M
- Amount sold
- $4.3M
- Proceeds to insiders
- $300K
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.1MraisedJun 2017 · 26 investors · PharmaceuticalsRule 506(b)
▶$4.1MraisedJun 2017 · 26 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David PfeifferExecutive Officer, Director
- Somu SubramaniamDirector
- Stephen TullmanExecutive Officer, Director
- Douglas GesslExecutive Officer
- Neal WalkerDirector
- Jason HongDirector
- Offering amount
- $6.9M
- Amount sold
- $4.1M
- Minimum investment
- $2.9K
- Proceeds to insiders
- $600K
- First sale
- May 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$10.6MraisedApr 2015 · 35 investors · PharmaceuticalsRule 506(b)
▶$10.6MraisedApr 2015 · 35 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Stephen TullmanDirector
- Somu SubramaniamDirector
- Raju MohanExecutive Officer
- Kamil Ali-JacksonExecutive Officer
- Jason HongDirector
- Neal WalkerDirector
- David PfeifferExecutive Officer, Director
- Douglas GesslExecutive Officer
- Offering amount
- $21.5M
- Amount sold
- $10.6M
- Minimum investment
- $12.5K
- Proceeds to insiders
- $2.9M
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Alexar Therapeutics?
- Alexar Therapeutics was founded by Raju Mohan in 2013.
- Who are Alexar Therapeutics's investors?
- Alexar Therapeutics's investors include New Science Ventures, Third Point Ventures.
- How much funding has Alexar Therapeutics raised?
- Alexar Therapeutics has disclosed $19M raised across 3 rounds.
- Where is Alexar Therapeutics headquartered?
- Alexar Therapeutics is headquartered in Malvern, US.